维普期刊资源整合服务平台（V6.5）

33篇 您的检索式：作者名="Andersen FA"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy显示文摘	Andersen S van Nieuwenhoven FA	2005	Kidney Inter2005，67，：	1
2	Final amended safety assessment of hydroquinone as used in cosmetics 显示文摘	Andersen FA Bergfeld WF Belsito DV	2010	Int J Toxicol2010，29，6：	1
3	Final report on the safety assessment of phloroglucinol 显示文摘	Andersen FA	1996	J Am Cell Toxieol1996，14，6：	1
4	Final report on the safety assessment of phloroglucinol 显示文摘	Andersen FA	1996	Am Cell Toxicol1996，14，：	1
5	Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy显示文摘	Andersen S van Nieuwenhoven FA Tarnow L	2005	Kidney Int2005，67，6：	1
6	Final report on the safety assessment of phloroglucinol显示文摘	Andersen FA	1996	J Am Cell Toxicol1996，14，6：	1
7	Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy显示文摘	Andersen S van Nieuwenhoven FA Tarnow L	2005	Kidney Int2005，67，6：	1
8	Effects of combined methohexitone-remifentanil anaesthesia in electroconvulsive therapy显示文摘	Andersen FA Arsland D Holst-iarsen H	2001	Acta Anaesthesiol Stand2001，45，：	1
9	Final report on the safety assessment of phloroglucinol显示文摘	Andersen FA	1996	J Am Cell Toxicol1996，14，6：	1
10	Final safety assessment for PCA and sodium PCA显示文摘	ANDERSEN FA	1999	Int J Toxicol1999，18，25：	1
11	Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropa- thy显示文摘	Andersen S van Nieuwenhoven FA Tarnow L	2005	Kidney Int2005，67，6：	1
12	Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy显示文摘	Andersen S van Nieuwenhoven FA Tarnow L	2005	Kidney Int2005，67，：	1
13	Reduction of urinary connective tissue growth factor by Losartan in type 1patients with diabetic nephropathy显示文摘	Andersen S van Nieuwenhove FA Tarnow L	2005	Kidney Int2005，67，6：	1
14	Final report on the safety assessment of phl- oroglusinol显示文摘	Andersen FA	1996	J Am Gell Toxicol1996，14，6：	1
15	Final amended safety assessment of hydroquinone as used in cosmeties 显示文摘	Andersen FA Bergfeld WF Belsito DV		lntJ Toxieol0，29，6：	1
16	Final report on the safety assessment of phloroglucinol显示文摘	Andersen FA	1995	J Am Cell Toxicol1995，14，6：	1
17	Final report on the safety assessment of phloroglucinol显示文摘	Andersen FA	1996	J Am Cell Toxicol1996，14，6：	1
18	Final report on the safety assessment of phloroglucinol显示文摘	Andersen FA	1996	J Am Cell Toxicol1996，14，6：	1
19	Final report on the safety assessment of phloroglucinol显示文摘	Andersen FA	1996	J Am cell Toxicol1996，14，6：	1
20	Multicentre,randomised, double blind, placebo controlled, phase IIIstudy of weekly, low dose,subcutaneous interferon beta-la in secondary progressive multiple sclerosis显示文摘	O Andersen I Elovaara M Fa	2004	NeurolNeurosurgPsychiatry2004，75，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示